Abstract 10: Efficacy and safety of semaglutide 2.4 mg once- weekly in adults with overweight or obesity and type 2 diabetes (STEP 2)

Background: In people with overweight/obesity and type 2 diabetes (T2D), achievement of weight loss can be a challenge. STEP 2 investigated the efficacy and safety of semaglutide 2.4 mg for weight management in adults with overweight/obesity and T2D. Methods: This randomized, double-blind, double-du...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahman, Syed Kasfur, Davies, Melanie, Færch, Louise, Jeppesen, Ole K, Pakseresht, Arash, Pedersen, Sue D, Perreault, Leigh, Rosenstock, Julio, Shimomura, Iichiro, Viljoen, Adie, Wadden, Thomas A, Lingvay, Ildiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Abstracts … Esicon 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067799/
http://dx.doi.org/10.4103/2230-8210.342311

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067799/
http://dx.doi.org/10.4103/2230-8210.342311

Ejemplares similares